Skip to main content
Top
Published in: Techniques in Coloproctology 6/2015

01-06-2015 | Original Article

Flavonoids mixture (diosmin, troxerutin, hesperidin) in the treatment of acute hemorrhoidal disease: a prospective, randomized, triple-blind, controlled trial

Authors: I. Giannini, A. Amato, L. Basso, N. Tricomi, M. Marranci, G. Pecorella, S. Tafuri, D. Pennisi, D. F. Altomare

Published in: Techniques in Coloproctology | Issue 6/2015

Login to get access

Abstract

Background

The role of a mixture of phlebotonics in the treatment of acute hemorrhoid crisis is investigated to test their efficacy.

Methods

One hundred and thirty-four consecutive patients with an acute hemorrhoidal crisis recruited in five colorectal units entered the study. Sixty-six of them were randomized to receive a mixture of diosmin, troxerutin and hesperidin (group A), and 68 a placebo (group B). The main symptoms, the use of oral painkillers and the Bristol scale score were recorded at each scheduled visit and compared using both Student’s t test for independent samples and the ANOVA models for repeated measures. The presence of edema, prolapse and thrombosis were also recorded and compared using the Chi-square test. Furthermore, the trend of proportions during the time of the evaluations was assessed by the Chi-square test for linear trend.

Results

Pain, bleeding and the proportion of patients who reported persistence of edema and thrombosis decreased significantly after 12 days of treatment in group A. After 6 days, the number of paracetamol tablets taken by patients in group A was significantly lower than the amount of flavonoid mixture.

Conclusions

The use of a mixture of diosmin, troxerutin and hesperidin is a safe and effective mean of managing symptoms of acute hemorrhoidal disease. Furthermore, in patients receiving treatment, there was faster control and lower persistence of edema and thrombosis.
Literature
1.
go back to reference Altomare DF, Giannini I (2013) Pharmacological treatment of hemorrhoids: a narrative review. Expert Opin Pharmacother 14:2343–2349CrossRefPubMed Altomare DF, Giannini I (2013) Pharmacological treatment of hemorrhoids: a narrative review. Expert Opin Pharmacother 14:2343–2349CrossRefPubMed
2.
go back to reference Perera N, Liolitsa D, Iype S (2012) Phlebotonics for haemorrhoids. Cochrane Database Syst Rev 8:CD004322PubMed Perera N, Liolitsa D, Iype S (2012) Phlebotonics for haemorrhoids. Cochrane Database Syst Rev 8:CD004322PubMed
3.
go back to reference Altomare DF, Roveran A, Pecorella G, Gaj F, Stortini E (2006) The treatment of hemorrhoids: guidelines of the Italian society of colorectal surgery. Tech Coloproctol 10:181–186CrossRefPubMed Altomare DF, Roveran A, Pecorella G, Gaj F, Stortini E (2006) The treatment of hemorrhoids: guidelines of the Italian society of colorectal surgery. Tech Coloproctol 10:181–186CrossRefPubMed
4.
go back to reference Rivadeneira DE, Steele SR, Ternent C et al (2011) Standards practice task force of the american society of colon and rectal surgeons. Practice parameters for the management of hemorrhoids (revised 2010). Dis Colon Rectum 54:1059–1064CrossRefPubMed Rivadeneira DE, Steele SR, Ternent C et al (2011) Standards practice task force of the american society of colon and rectal surgeons. Practice parameters for the management of hemorrhoids (revised 2010). Dis Colon Rectum 54:1059–1064CrossRefPubMed
5.
go back to reference Ho YH, Tan M, Seow-Choen F (2000) Micronized purified flavonoid fraction compared favourably with rubber band ligations and fiber alone in the management of bleeding haemorrhoids: randomized controlled trial. Dis Colon Rectum 43:66–69CrossRefPubMed Ho YH, Tan M, Seow-Choen F (2000) Micronized purified flavonoid fraction compared favourably with rubber band ligations and fiber alone in the management of bleeding haemorrhoids: randomized controlled trial. Dis Colon Rectum 43:66–69CrossRefPubMed
6.
go back to reference Khubchandani IT (2001) Randomized clinical trial of micronized flavonoids in the early control of bleeding for acute internal haemorrhoids. Tech Coloproctol 5:57–58PubMed Khubchandani IT (2001) Randomized clinical trial of micronized flavonoids in the early control of bleeding for acute internal haemorrhoids. Tech Coloproctol 5:57–58PubMed
7.
go back to reference Labrid C (1994) Pharmacologic properties of Daflon 500 mg. Angiology 45:524–530PubMed Labrid C (1994) Pharmacologic properties of Daflon 500 mg. Angiology 45:524–530PubMed
8.
go back to reference Labrid C (1995) A lymphatic function of Daflon 500 mg. Int Angiol 14:36–38PubMed Labrid C (1995) A lymphatic function of Daflon 500 mg. Int Angiol 14:36–38PubMed
9.
go back to reference Struckmann JR, Nicolaides AN (1994) Flavonoids. A review of the pharmacology and therapeutic efficacy of Daflon 500 mg in patients with chronic venous insufficiency and related disorders. Angiology 45:419–428CrossRefPubMed Struckmann JR, Nicolaides AN (1994) Flavonoids. A review of the pharmacology and therapeutic efficacy of Daflon 500 mg in patients with chronic venous insufficiency and related disorders. Angiology 45:419–428CrossRefPubMed
10.
go back to reference Bartoli M (2013) Efficacia Farmacologica di diversi flebotonici sulla risposta contrattile alla noradrenalina di safene umane isolate. Il Continuum del paziente vascolare 1:2–3 Bartoli M (2013) Efficacia Farmacologica di diversi flebotonici sulla risposta contrattile alla noradrenalina di safene umane isolate. Il Continuum del paziente vascolare 1:2–3
11.
go back to reference Fortini C, Morelli C, Fiorelli V (2010) Effetto biologico di una formulazione a base di diosmina, esperidina, troxerutina (Triade) sulle permeabilità dell’endotelio vasale umano. Il Continuum del paziente vascolare 1:12–16 Fortini C, Morelli C, Fiorelli V (2010) Effetto biologico di una formulazione a base di diosmina, esperidina, troxerutina (Triade) sulle permeabilità dell’endotelio vasale umano. Il Continuum del paziente vascolare 1:12–16
13.
go back to reference Belcaro G, Rosaria Cesarone M, Ledda A et al (2008) O-(beta-hydroxyethyl)-rutosides systemic and local treatment in chronic venous disease and microangiopathy: an independent prospective comparative study. Angiology 59(Suppl 1):7S–13SCrossRefPubMed Belcaro G, Rosaria Cesarone M, Ledda A et al (2008) O-(beta-hydroxyethyl)-rutosides systemic and local treatment in chronic venous disease and microangiopathy: an independent prospective comparative study. Angiology 59(Suppl 1):7S–13SCrossRefPubMed
14.
go back to reference Cesarone MR, Belcaro G, Pellegrini L et al (2006) Venoruton verus Daflon: evaluation of effects on quality of life in chronic venous insufficiency. Angiology 57:131–138CrossRefPubMed Cesarone MR, Belcaro G, Pellegrini L et al (2006) Venoruton verus Daflon: evaluation of effects on quality of life in chronic venous insufficiency. Angiology 57:131–138CrossRefPubMed
15.
go back to reference Danielsson G, Jungbeck C, Peterson K, Norgren L (2002) A randomised controlled trial of micronised purified flavonoid fraction vs placebo in patients with chronic venous disease. Eur J Vasc Endovasc Surg 23:73–76CrossRefPubMed Danielsson G, Jungbeck C, Peterson K, Norgren L (2002) A randomised controlled trial of micronised purified flavonoid fraction vs placebo in patients with chronic venous disease. Eur J Vasc Endovasc Surg 23:73–76CrossRefPubMed
16.
go back to reference Jantet G (2000) RELIEF study: first consolidated European data. Reflux assessment and quality of life improvement with micronized flavonoids. Angiology 51:31–37CrossRefPubMed Jantet G (2000) RELIEF study: first consolidated European data. Reflux assessment and quality of life improvement with micronized flavonoids. Angiology 51:31–37CrossRefPubMed
17.
go back to reference Jantet G (2002) Chronic venous insufficiency: worldwide results of the RELIEF study. Reflux assessment and quality of life improvement with micronized flavonoids. Angiology 53:245–256CrossRefPubMed Jantet G (2002) Chronic venous insufficiency: worldwide results of the RELIEF study. Reflux assessment and quality of life improvement with micronized flavonoids. Angiology 53:245–256CrossRefPubMed
18.
go back to reference Stuard S, Cesarone MR, Belcaro G et al (2008) Five-year treatment of chronic venous insufficiency with O-(β-hydroxyethyl)-rutosides: safety aspects. Int J Angiol 17:143–148PubMedCentralCrossRefPubMed Stuard S, Cesarone MR, Belcaro G et al (2008) Five-year treatment of chronic venous insufficiency with O-(β-hydroxyethyl)-rutosides: safety aspects. Int J Angiol 17:143–148PubMedCentralCrossRefPubMed
19.
go back to reference Alonso-Coello P, Zhou Q, Martinez-Zapata MJ et al (2006) Meta-analysis of flavonoids for the treatment of haemorrhoids. Br J Surg 93:909–920CrossRefPubMed Alonso-Coello P, Zhou Q, Martinez-Zapata MJ et al (2006) Meta-analysis of flavonoids for the treatment of haemorrhoids. Br J Surg 93:909–920CrossRefPubMed
20.
go back to reference La Torre F, Nicolai AP (2004) Clinical use of micronized purified flavonoid fraction for treatment of symptoms after hemorrhoidectomy: results of a randomized, controlled, clinical trial. Dis Colon Rectum 47:704–710CrossRefPubMed La Torre F, Nicolai AP (2004) Clinical use of micronized purified flavonoid fraction for treatment of symptoms after hemorrhoidectomy: results of a randomized, controlled, clinical trial. Dis Colon Rectum 47:704–710CrossRefPubMed
Metadata
Title
Flavonoids mixture (diosmin, troxerutin, hesperidin) in the treatment of acute hemorrhoidal disease: a prospective, randomized, triple-blind, controlled trial
Authors
I. Giannini
A. Amato
L. Basso
N. Tricomi
M. Marranci
G. Pecorella
S. Tafuri
D. Pennisi
D. F. Altomare
Publication date
01-06-2015
Publisher
Springer Milan
Published in
Techniques in Coloproctology / Issue 6/2015
Print ISSN: 1123-6337
Electronic ISSN: 1128-045X
DOI
https://doi.org/10.1007/s10151-015-1302-9

Other articles of this Issue 6/2015

Techniques in Coloproctology 6/2015 Go to the issue